CABERGLOW 0.50 

Cabergoline IP(0.5mg)

 Introduction

CABERGLOW 0.50 is a medication containing Cabergoline IP (0.5 mg), a potent dopamine agonist used to treat various medical conditions related to hormonal imbalances. Cabergoline works by stimulating dopamine receptors in the brain, which helps regulate the production of certain hormones. This medication is commonly prescribed for conditions such as hyperprolactinemia and Parkinson's disease. CABERGLOW 0.50 is designed to offer a targeted and effective treatment for these conditions, improving patient outcomes and quality of life.

Uses

CABERGLOW 0.50 is used primarily for the following conditions:

1. Hyperprolactinemia: Cabergoline is primarily prescribed to treat hyperprolactinemia, a condition characterized by elevated levels of prolactin, a hormone produced by the pituitary gland. Elevated prolactin levels can lead to symptoms such as irregular menstrual cycles, infertility, and galactorrhea (excessive milk production). CABERGLOW 0.50 helps reduce prolactin levels by stimulating dopamine receptors, which inhibit prolactin secretion.

2. Parkinson’s Disease: Cabergoline can also be used as part of the treatment regimen for Parkinson’s disease. It helps manage symptoms such as tremors, stiffness, and bradykinesia (slowness of movement) by mimicking the action of dopamine in the brain, thereby improving motor function and quality of life in patients with Parkinson’s disease.

3. Acromegaly: In some cases, CABERGLOW 0.50 may be used to treat acromegaly, a condition caused by excess growth hormone, which leads to abnormal growth of bones and tissues. Cabergoline helps control growth hormone levels by acting on dopamine receptors in the pituitary gland.

Dosage

The dosage of CABERGLOW 0.50 should be determined by a healthcare professional based on the specific condition being treated and the patient’s response to the medication. Typical dosage guidelines include:

• For Hyperprolactinemia: The initial dose is usually 0.5 mg twice a week, which can be adjusted based on the patient’s prolactin levels and tolerance. The dose may be gradually increased to a maximum of 2 mg per week as needed.

• For Parkinson’s Disease: The usual starting dose is 0.5 mg once or twice a week, with gradual adjustments based on the patient’s response and side effects. The dose can be increased up to 3 mg per week if required.

• For Acromegaly: The initial dose is typically 0.25 mg twice a week, which may be increased to a maximum of 1 mg twice a week based on patient response and tolerability.

Side Effects

While CABERGLOW 0.50 is generally well-tolerated, some patients may experience side effects. Common side effects include:

• Nausea and Vomiting: Some individuals may experience gastrointestinal discomfort, including nausea and vomiting.
• Dizziness and Headache: Dizziness and headaches are possible, particularly when starting the medication or adjusting the dose.
• Fatigue: Patients might feel fatigued.
• Low Blood Pressure: Cabergoline can cause a drop in blood pressure, leading to symptoms such as lightheadedness or fainting.
• Mood Changes: Rarely, patients may experience mood swings or behavioral changes.

Severe side effects are less common but may include hallucinations, severe allergic reactions, and heart valve issues. It is important to report any unusual or severe symptoms to a healthcare provider promptly.

Price

The price of CABERGLOW 0.50 can vary depending on the country, pharmacy, and insurance coverage. On average, a pack of CABERGLOW 0.50, which typically contains a month's supply, may cost between INR 800 to INR 1500. Prices may vary based on local regulations, brand variations, and availability. It is advisable to compare prices at different pharmacies and check for any available discounts or insurance coverage to obtain the best value.

Conclusion

CABERGLOW 0.50, containing Cabergoline IP (0.5 mg), is a valuable medication for managing conditions associated with hormonal imbalances, including hyperprolactinemia, Parkinson’s disease, and acromegaly. By stimulating dopamine receptors, CABERGLOW 0.50 helps regulate hormone levels and improve symptoms related to these conditions. Proper dosing and monitoring are essential to achieving optimal results while minimizing side effects. As with any medication, it is important to use CABERGLOW 0.50 under the guidance of a healthcare professional to ensure its safety and effectiveness. Whether managing hormonal imbalances or neurological symptoms, CABERGLOW 0.50 offers a targeted approach to improving patient outcomes and quality of life. Steris Healthcare Pvt Ltd, operating as Sterispharma since its founding by expert professionals in the pharmaceutical industry in February 2018, is based in Navi Mumbai. The company is certified by WHO, GMP, and ISO, emphasizing its commitment to quality and safety. Sterispharma focuses on providing high-quality drugs at affordable prices throughout India, adhering strictly to WHO guidelines. Offering the convenience of an online pharmacy, customers can easily purchase medicines with home delivery options available. Sterispharma's mission is to supply a broad range of healthcare products to meet the diverse needs of the medical community. From advanced treatments and medications for rare conditions to essential health necessities, Sterispharma aims to serve the extensive demands of the healthcare industry. You can order medicines from Sterispharma through their websites, sterisonline and sterispharma. Their extensive product lineup includes treatments for Cardiology, Asthma, Respiratory Issues, Nasal Conditions, Diabetes, Endocrinology, Gastroenterology, Orthopedics, Anti-infectives/Antibiotics, General Medicine, Urology, Neurology, Nephrology, Oncology, Gynecology, Pediatrics, Dental Care, and Dermatology.

For further information 

Email: info@sterispharma.com /  contact@sterispharma.com

Call/WhatsApp:  7877551268, 7849827488 

BUY NOW